Literature DB >> 21786179

Comparative study of the immunohistochemical expression of tissue inhibitors of metalloproteinases 1 and 2 between clearly invasive carcinomas and "in situ" trophoblast invasion.

Blerta Dimo1, Ioannis Ioannidis, Andreas Karameris, George Vilaras, Panagiota Tzoumakari, Aphrodite Nonni, Eystratios Patsouris, Andreas C Lazaris.   

Abstract

Tissue inhibitors of metalloproteinases (TIMPs) play an important role in extracellular matrix homeostasis by regulating MMP activity. Although they were initially considered inhibitors of tumor growth and metastasis, recently their role in cancer progression has been controversial. The aim of our study was to compare the immunohistochemical expression of TIMP1 and TIMP2 between an uncontrollably invasive phenomenon (cancer) and an "in situ" process (trophoblast invasion) in an effort to assess any differential role of these molecules between these two distinct phenomena and therefore to understand better their contribution in cancer invasion and migration. We performed an immunohistochemical analysis of 50 carcinomas (colorectal, gastric, breast, pulmonary, and renal) and 40 first trimester gestations. The marker expression was evaluated semiquantitatively, separately in cancer parenchymal and trophoblastic cells as well as in malignant stromal and decidual cells, according to a percentage scale (0, <10, 10-50, and >50%) and according to staining intensity (0, +, ++, and +++). Our results showed that there was no statistically significant difference in TIMP1 expression between cancer parenchymal cells and trophoblastic cells. On the other hand, TIMP1 was expressed more often in decidual cells than in cancer stromal cells. Immunostaining for TIMP2 was more extensive and intense both in trophoblastic and decidual cells than in cancer parenchymal and stromal cells, respectively. The reduced expression of TIMP2 in metastatic carcinomas by comparison with non-metastatic gestation specimens underlines its importance in cancer invasion and migration. On the other hand, TIMP1 was more expressed in decidua than cancer stroma, but at the same time showed no statistically significant difference between cancer parenchyma and trophoblasts, highlighting its multifunctional activity in cancer progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21786179     DOI: 10.1007/s12032-011-0032-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  18 in total

Review 1.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

Review 2.  TIMPs as multifacial proteins.

Authors:  Elise Lambert; Emilie Dassé; Bernard Haye; Emmanuelle Petitfrère
Journal:  Crit Rev Oncol Hematol       Date:  2004-03       Impact factor: 6.312

Review 3.  Role of proteases in implantation.

Authors:  L A Salamonsen
Journal:  Rev Reprod       Date:  1999-01

Review 4.  Complex roles of tissue inhibitors of metalloproteinases in cancer.

Authors:  Yangfu Jiang; Itzhak D Goldberg; Y Eric Shi
Journal:  Oncogene       Date:  2002-03-28       Impact factor: 9.867

5.  Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum.

Authors:  T Hayakawa; K Yamashita; K Tanzawa; E Uchijima; K Iwata
Journal:  FEBS Lett       Date:  1992-02-17       Impact factor: 4.124

6.  Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human preimplantation embryos.

Authors:  Hongbo Wang; Yan Wen; Stephen Mooney; Hao Li; Barry Behr; Mary Lake Polan
Journal:  Fertil Steril       Date:  2003-09       Impact factor: 7.329

7.  Mechanism of control of trophoblast invasion in situ.

Authors:  C H Graham; P K Lala
Journal:  J Cell Physiol       Date:  1991-08       Impact factor: 6.384

Review 8.  Emerging roles for proteinases in cancer.

Authors:  A Noël; C Gilles; K Bajou; L Devy; F Kebers; J M Lewalle; E Maquoi; C Munaut; A Remacle; J M Foidart
Journal:  Invasion Metastasis       Date:  1997

Review 9.  ECM signalling: orchestrating cell behaviour and misbehaviour.

Authors:  M E Lukashev; Z Werb
Journal:  Trends Cell Biol       Date:  1998-11       Impact factor: 20.808

Review 10.  Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development.

Authors:  C V Hojilla; F F Mohammed; R Khokha
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

View more
  4 in total

1.  Regulation of trophoblast invasion: the role of matrix metalloproteinases.

Authors:  Jia-Yu Zhu; Zhan-Jun Pang; Yan-Hong Yu
Journal:  Rev Obstet Gynecol       Date:  2012

2.  Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.

Authors:  Yang Dong; Wei-Ming Ma; Wen Yang; Lin Hao; Shao-Qi Zhang; Kun Fang; Chun-Hui Hu; Qian-Jin Zhang; Zhen-Duo Shi; Wen-da Zhang; Tao Fan; Tian Xia; Cong-Hui Han
Journal:  BMC Cancer       Date:  2021-10-23       Impact factor: 4.430

3.  Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma.

Authors:  Simone Magagnin Wajner; Clarissa Capp; Beatriz Assis Brasil; Luise Meurer; Ana Luiza Maia
Journal:  Oncol Lett       Date:  2013-12-19       Impact factor: 2.967

4.  Sphingosine kinases negatively regulate the expression of matrix metalloproteases (MMP1 and MMP3) and their inhibitor TIMP3 genes via sphingosine 1-phosphate in extravillous trophoblasts.

Authors:  Kirti R Chahar; Vijay Kumar; Phulwanti K Sharma; Daniela Brünnert; Vibha Kaushik; Pragya Gehlot; Indu Shekhawat; Suman Kumar; Ajay Kumar Sharma; Sandhya Kumari; Pankaj Goyal
Journal:  Reprod Med Biol       Date:  2021-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.